The stocks are included in the investment bank's "Conviction List - Directors' Cut" group of buy-rated companies.| CNBC
Medtech Big 100 revenue hit a new record high, but collective R&D spending by the world’s largest medical device companies is leveling off. By Managing Editor Jim Hammerand and Senior Editor Danielle Kirsh Aggregate research and development spending growth across the world’s largest medical device companies is grinding to a halt after double-digit growth in… The post R&D alert: Research and development spending stalls in the 2025 Medtech Big 100 ranking appeared first on Research & Deve...| Research & Development World
Johnson & Johnson (NYSE:JNJ) announced today that it plans to increase its biopharmaceutical manufacturing presence in North Carolina. The company committed $2 billion toward a 160,000+-square-foot dedicated manufacturing facility at Fujifilm’s new biopharmaceutical manufacturing site in Holly Springs, North Carolina. Its commitment spans the next 10 years, expanding its U.S. manufacturing capacity and creating approximately… The post Johnson & Johnson commits $2B investment to North Caro...| Pharmaceutical Processing World
UTA’s Junzhou Huang secures $3.1M NIH grant to advance AI-driven antibody drug discovery, aiming to speed pandemic response and lower development costs.| Dallas Innovates
A fully independent clinical trial researchers thought might disprove a cardiac device made by Shockwave Medical, the company that Johnson & Johnson is buying for $13 billion, ended up providing some support for the device’s utility.| Healthcare Weekly
By embracing diverse perspectives, actively countering biases, and holding leaders accountable, organizations can create environments where every employee has the opportunity to succeed.| Bluesky Thinking
David Levine and Bruce Wydick Americans—and the world—should cheer the government’s news Friday to lift the pause on the distribution of the Johnson & Johnson COVID-19 vaccine. The decision wi…| Across Two Worlds